Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Apr 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1296751000001110 | Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes 1 pre-filled disposable injection | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1296761000001113 | Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes 1 pre-filled disposable injection (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes 1 pre-filled disposable injection | Has VMP | Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes | true | Inferred relationship | Existential restriction modifier | ||
| Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes 1 pre-filled disposable injection | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes 1 pre-filled disposable injection | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes 1 pre-filled disposable injection | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes 1 pre-filled disposable injection | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes 1 pre-filled disposable injection | Has dispensed dose form | Conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes 1 pre-filled disposable injection | Has specific active ingredient | Brolucizumab | false | Inferred relationship | Existential restriction modifier | ||
| Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes 1 pre-filled disposable injection | Has specific active ingredient | Brolucizumab | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Beovu 19.8mg/0.165ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) 1 pre-filled disposable injection | Is a | True | Brolucizumab 19.8mg/0.165ml solution for injection pre-filled syringes 1 pre-filled disposable injection | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR